Supreme Court rules on fight between drugmakers in "skinny label" patent case
The Supreme Court issued a ruling backing a generic drugmaker accused of infringing Amarin Pharma patents for so-called "skinny labels." CBS News' Jan Crawford reports.
Original Source
Read the full article at Cbsnews →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.